NCT02345421View on ClinicalTrials.gov

A Study to Identify and Characterize LAL-D Patients in High-risk Populations

TerminatedOBSERVATIONAL
Enrollment

640

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

October 31, 2015

Conditions
Lysosomal Acid Lipase Deficiency
Trial Locations (15)

Unknown

Birmingham

Phoenix

Los Angeles

San Francisco

Gainesville

Jacksonville

Miami

New Orleans

Minneapolis

The Bronx

Durham

Oklahoma City

Portland

Houston

San Antonio

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY